NLRP3 and lymphoma: The recent observation that high glucose is able to activate the EBV lytic switch via the NLRP3 inflammasome [58] and that increased lytic activation predisposes the development of EBV-lymphomas [3] together provide a mechanistic basis for this important clinical observation.